New diabetes clinical trial: Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy

Published on: 2026-03-30T04:00:00Z
Conditions: Neovascular (Wet) Age-Related Macular Degeneration; Retinal Vein Occlusion; Diabetic Macular Edema; Diabetic Retinopathy
Interventions: Drug: SCD411 0.05mL (2mg)
Sponsors: Sam Chun Dang Pharm. Co. Ltd.
Not yet recruiting
https://ift.tt/RjytXTd